[Features of Insulin Secretion and Insulin Resistance in Newly Diagnosed Type 2 Diabetes of Different Body Mass Indices].
Ya-Li An,Yan Gao,Qian Zhu,Guang Ning,Wei-Ping Jia,Qin Huang,Wen Xu,Cheng-Jiang Li,Zhi-Guang Zhou,Bing-Yin Shi,Zhong-Yan Shan,Lu-Lu Chen,Zhang-Rong Xu,Heng Wang,Li Yan,Hui-Ju Zhong,Qiu-He Ji,Hong Li,Yuan-Ming Xue,Mu-Xun Zhing,Wei Gu,Xiao-Hui Guo,Lei-Li Gao,Jie Hong,Fang Liu,Da-Jin Zou,Yan-Bing Li,Xiao-Ying Zhang,Zhen Li,Gui Guo,Xiao-Juan Zhao,Han-Ni Wu,Yu-Zhen Wang,Wei-Gang Zhao,Shao-Lin Zhang,Jing Wu,Nan-Yan Zhang,Feng-Ying Yang,Yun Zhang,Xin-Rong Zhou,Yue-Zhong Ren,Guang-Wei Li
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2009.16.012
2009-01-01
Abstract:OBJECTIVE:To investigate insulin secretion function and insulin resistance in Chinese newly diagnosed type 2 diabetes (obese and non-obese patients) in order to provide evidence for clinical treatment. METHODS:408 newly diagnosed type 2 diabetes and 40 normal controls were recruited. Height, weight were measured, insulin and glucose of 0 min, 30 min, 60 min, 120 min during oral glucose tolerance test were examined. The patients with fasting glucose level greater than 8.3mmol/L were treatment with Gliclazide for 1 - 3 months. After normalization of the plasma glucose levels for more than 2 weeks, and withdraw this medication for 48 hours, then OGTT were repeated to assess IR and IS. RESULTS:The patients were divided into four groups based on fasting plasma glucose (DM1: FPG < 6.9mmol/L; DM2: 6.9 mmol/L < or = FPG < 8.3 mmol/L; DM3: 8.3 mmol/L < or = FPG < 9.7 mmol/L; DM4: FPG > or = 9.7 mmol/L). Every groups were further stratified to subgroups by cut point of BMI = 24 kg/m(2). Their insulin sensitivity and insulin secretion function compared between subgroups. (1) True insulin level in BMI > or = 24 (FPG < 6.9 mmol/L) subgroups were higher than control's (3.5 +/- 0.5 vs 3.2 +/- 0.6 natural logarithm) (P < 0.05). (2) In BMI > or = 24 subgroups, their insulin sensitivity were even worse than BMI < 24 groups', but their insulin secretion function were better at the same FPG level. (3) After intervention, the change of insulin sensitivity in BMI < 24 group was better than BMI > or = 24 group's (-4.7 +/- 0.9 vs -5.5 +/- 1.4 natural logarithm) (P < 0.05); but the change of insulin secretion function in BMI < 24 group was worse. CONCLUSION:(1) In newly diagnostic type 2 diabetes, insulin sensitivity and insulin secretion function were decreased with the increase of FPG, but they were different between obese and non-obese group. (2) Insulin secretion function was recovered better in obese group when eliminated glucose toxicity.